The effect of asymptomatic infection with HTLV-III on the response of anogenital warts to intralesional treatment with recombinant alpha 2 interferon

J Infect Dis. 1986 Aug;154(2):331-4. doi: 10.1093/infdis/154.2.331.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Viral / analysis
  • Anus Neoplasms / complications
  • Anus Neoplasms / therapy
  • Condylomata Acuminata / complications
  • Condylomata Acuminata / therapy*
  • Deltaretrovirus / immunology
  • Female
  • Genital Neoplasms, Female / complications
  • Genital Neoplasms, Female / therapy
  • Genital Neoplasms, Male / complications
  • Genital Neoplasms, Male / therapy
  • HIV Antibodies
  • Homosexuality
  • Humans
  • Interferon Type I / therapeutic use*
  • Male
  • Middle Aged
  • Recombinant Proteins / therapeutic use
  • Retroviridae Infections / complications*
  • Sexually Transmitted Diseases / complications
  • Sexually Transmitted Diseases / therapy

Substances

  • Antibodies, Viral
  • HIV Antibodies
  • Interferon Type I
  • Recombinant Proteins